arrow
D

Dilek Çağlayan

Necmettin Erbakan University
H指数:5
被引数:73

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

三阴性乳腺癌新辅助化疗患者的CPS-EG评分的预后意义

Cancers
IF4.4
2026-08-180
OA
The Impact of Concurrent Proton Pump Inhibitors on Nivolumab Response in Metastatic Non-Small Cell Lung Cancer: A Multicenter Real-Life Study

质子泵抑制剂对转移性非小细胞肺癌中纳武利尤单抗疗效的影响:一项多中心真实世界研究

2026-01-200
PRE
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study

靶向疗法在肺鳞状细胞癌转移中的疗效:一项土耳其肿瘤学组多中心研究

2025-12-010
PRE
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study (vol 14, 23556, 2024)
2025-03-180
OAAI
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)
2024-01-230
OAAI
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
2024-01-022
OAAI
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer

HER2-positive转移性胃和胃食管交界处癌患者的一线治疗

2022-04-172
OA